Genmab: Darzalex Continues To Impress, Epcoritamab One Step Closer To Market
teekid/E+ via Getty Images Shares of Genmab (GMAB) rallied nearly 40% since my late June article, making the stock less attractive considering the lack of significant changes to the long-term outlook, but the company did […]
